Oaktree Acquisition Corporation II
PROPOSED BUSINESS COMBINATION: Alvotech Holdings S.A.
ENTERPRISE VALUE: $2.25 billion
ANTICIPATED SYMBOL: ALVO
Oaktree Acquisition Corp. II proposes to combine with Alvotech Holdings S.A., a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. ...READ MORE
